Aritro Nath Selected Research

Aritro Nath Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 11/2012
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 12/2017
2	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 01/2013
1	Brain Edema (Cerebral Edema) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Glioma (Gliomas) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Osteosarcoma (Osteogenic Sarcoma) 10/2021
1	Hand-Foot Syndrome 06/2020
1	Diarrhea 06/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017
1	Drug-Related Side Effects and Adverse Reactions 04/2017
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Insulin Resistance 01/2011
1	Non-alcoholic Fatty Liver Disease 01/2011
1	Virus Diseases (Viral Diseases) 10/2010

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 10/2021 - 11/2012
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2012
4	Long Noncoding RNAIBA 10/2021 - 04/2017
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2010
3	PalmitatesIBA 01/2021 - 01/2011
2	Estrogen ReceptorsIBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2016
2	MicroRNAs (MicroRNA)IBA 12/2019 - 04/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	LigandsIBA 01/2022
1	Receptor for Advanced Glycation End ProductsIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	Pharmacological BiomarkersIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Desmoplakins (Desmoplakin)IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 06/2020
1	ribociclibIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	veliparibIBA 12/2017
1	Lenalidomide (CC 5013)FDA Link 12/2017
1	AfatinibIBA 12/2017
1	AZD 6244IBA 12/2017
1	Gefitinib (Iressa)FDA Link 12/2017
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2016
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2016
1	tributyl phosphate (TBP)IBA 01/2016
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016
1	EpitopesIBA 10/2015
1	Pertussis ToxinIBA 10/2015
1	AntibodiesIBA 10/2015
1	Nonesterified Fatty Acids (NEFA)IBA 10/2015
1	Tumor Biomarkers (Tumor Markers)IBA 11/2012
1	eIF-2 Kinase (eIF 2 Kinase)IBA 10/2010
1	Insulin (Novolin)FDA Link 10/2010
1	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2010

Therapy/Procedure

6	Therapeutics 01/2022 - 12/2017
5	Drug Therapy (Chemotherapy) 01/2022 - 04/2017
2	Precision Medicine 01/2021 - 01/2020
1	Neurosurgical Procedures 01/2022
1	Craniotomy 01/2022
1	Immunotherapy 01/2022